AUTHOR=Evdokimova Sevindzh F. , Kornietskaya Anna L. , Bolotina Larisa V. , Kolobayev Iliya V. , Fedenko Alexander A. , Kaprin Andrey D. 

TITLE=Conversion surgery for stage IV gastric cancer after third-line immunotherapy: a case report

JOURNAL=Frontiers in Oncology

VOLUME=Volume 14 - 2024

YEAR=2024

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1494669

DOI=10.3389/fonc.2024.1494669

ISSN=2234-943X

ABSTRACT=The 5-year overall survival rate for stage IV gastric cancer is lower than 10%, despite the development of systemic therapy. Conversion surgery has shown to improve survival outcomes in patients with durable clinical response on chemotherapy. We report a clinical case of a patient, who underwent conversion surgery after pembrolizumab in the third-line setting for stage IV gastric cancer. The patient did not have recurrence for 22 months after conversion surgery.